EXEMPA LIN MET XR 25/5/1000MG TAB

EXEMPA LIN MET XR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 25mg, Linagliptin 5mg, and Metformin HCL 1000mg—three proven antidiabetic agents working synergistically to improve glycemic control. Empagliflozin helps reduce blood glucose by promoting urinary glucose excretion, while Linagliptin enhances insulin secretion by inhibiting DPP-4 enzymes. Metformin improves insulin sensitivity and reduces hepatic glucose production. This combination addresses multiple pathways in type 2 diabetes management. Suitable for patients requiring intensified glycemic control when monotherapy or dual therapy is insufficient. Extended-release formulation ensures steady medication levels throughout the day for consistent therapeutic effect. Always use as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.